NeuPath Health Inc.
NPTH.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.81% | 17.75% | 24.57% | 23.78% | 3.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.81% | 17.75% | 24.57% | 23.78% | 3.87% |
| Cost of Revenue | 15.43% | 19.00% | 23.41% | 24.16% | 3.45% |
| Gross Profit | 12.13% | 12.48% | 29.75% | 22.29% | 5.77% |
| SG&A Expenses | 1.69% | 27.54% | 25.72% | 19.81% | 0.63% |
| Depreciation & Amortization | -6.13% | -3.88% | -4.08% | 2.67% | -3.46% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.87% | 19.54% | 22.83% | 22.90% | 2.82% |
| Operating Income | 95.55% | -97.58% | 231.78% | 45.41% | 81.14% |
| Income Before Tax | 348.89% | -165.26% | 109.16% | 13.24% | 36.50% |
| Income Tax Expenses | -30.96% | -219.70% | 126.77% | 121.99% | 119.15% |
| Earnings from Continuing Operations | 219.62% | -86.31% | 71.20% | -6.58% | 10.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 20.70% | -15.95% | 25.17% | -25.93% | -137.70% |
| Net Income | 178.21% | -67.66% | 62.21% | -13.78% | -2.64% |
| EBIT | 95.55% | -97.58% | 231.78% | 45.41% | 81.14% |
| EBITDA | 37.83% | 53.13% | 43.66% | 27.09% | 20.96% |
| EPS Basic | 178.43% | -67.74% | 61.54% | -13.16% | -2.00% |
| Normalized Basic EPS | 2,150.00% | -733.33% | 183.33% | 90.63% | 140.00% |
| EPS Diluted | 157.14% | -67.74% | 72.60% | -13.16% | 5.41% |
| Normalized Diluted EPS | 2,050.00% | -733.33% | 183.33% | 84.38% | 140.00% |
| Average Basic Shares Outstanding | 0.13% | -0.33% | 0.09% | 0.47% | -0.13% |
| Average Diluted Shares Outstanding | 3.68% | -0.33% | 3.31% | 2.62% | 1.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |